Mobilize to vaccinate: lessons learned from social mobilization for immunization in low and middle-income countries.

Social mobilization behavior change communication community engagement demand hesitancy immunization low- and middle-income countries

Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
03 05 2020
Historique:
pubmed: 30 8 2019
medline: 22 6 2021
entrez: 30 8 2019
Statut: ppublish

Résumé

Creating and sustaining demand for immunization services is a global priority to ensure that vaccine-eligible populations are fully protected from vaccine-preventable diseases. Social mobilization remains a key health promotion strategy used by low- and middle-income countries (LMICs) to promote vaccination demand. In this commentary, we synthesize illustrative evidence on successful social mobilization efforts promoting the uptake of immunization services in select LMICs. The first example focuses on Sierra Leone's routine immunization program during the Universal Child Immunization initiative in the late 1980s. We then give an example of India's establishment of a social mobilization network in the early- to mid-2000s to support polio elimination in high-risk communities. Thirdly, we highlight the complexities of social mobilization in a humanitarian emergency during the 2017-2018 diphtheria outbreak among displaced Rohingyas in camps and settlements in Bangladesh. Lastly, we draw upon examples from the introduction of the human papillomavirus vaccine in several countries. We then critically examine recurring challenges faced when implementing social mobilization for immunization in LMICs and offer practical recommendations for improvement.

Identifiants

pubmed: 31464551
doi: 10.1080/21645515.2019.1661206
pmc: PMC7227704
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1208-1214

Références

J Infect Dis. 2017 Jul 1;216(suppl_1):S260-S266
pubmed: 28838190
Lancet. 2004 May 22;363(9422):1709
pubmed: 15160720
J Health Commun. 2010;15 Suppl 1:25-47
pubmed: 20455165
Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S451-8
pubmed: 26553674
BMC Public Health. 2012 Aug 09;12:629
pubmed: 22877158
BMC Med Ethics. 2015 Jul 01;16:44
pubmed: 26126899
Am J Public Health. 2019 Mar;109(3):379-384
pubmed: 30676797
Annu Rev Psychol. 2018 Jan 4;69:357-381
pubmed: 28945979
Vaccine. 2016 Nov 4;34(46):5495-5503
pubmed: 27692772
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73
pubmed: 23584253
Health Aff (Millwood). 2016 Feb;35(2):277-83
pubmed: 26858381
Glob Health Sci Pract. 2014 Dec 10;2(4):381-94
pubmed: 25611473
Indian J Med Res. 2016 Jun;143(6):801-808
pubmed: 27748306
J Acquir Immune Defic Syndr. 2014 Jul 1;66 Suppl 2:S209-16
pubmed: 24918597
Vaccine. 2015 Aug 14;33(34):4215-7
pubmed: 25896378
Vaccine. 2015 Aug 14;33(34):4180-90
pubmed: 25896377
Asia Pac J Public Health. 1989;3(3):200-4
pubmed: 2620020
Vaccine. 2013 Jun 26;31(30):3072-8
pubmed: 23684835
BMC Infect Dis. 2013 Jan 17;13:17
pubmed: 23327427
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Lancet Glob Health. 2017 Jun;5(6):e593-e603
pubmed: 28495264
J Behav Med. 2019 Oct;42(5):991-997
pubmed: 30879225
PLoS One. 2012;7(10):e45231
pubmed: 23115621
Vaccine. 2019 Mar 7;37(11):1495-1502
pubmed: 30755367
Public Health. 2017 Feb;143:60-70
pubmed: 28159028
Glob Health Sci Pract. 2013 Mar 21;1(1):68-83
pubmed: 25276518
Vaccine. 2017 Dec 14;35(49 Pt B):6915-6923
pubmed: 28716555
J Infect Dis. 2003 May 15;187 Suppl 1:S291-8
pubmed: 12721928
Soc Sci Med. 1992 Oct;35(7):851-6
pubmed: 1411685
BMC Public Health. 2016 Aug 19;16(1):834
pubmed: 27543037
Vaccine. 2019 Feb 4;37(6):833-838
pubmed: 30642728
Indian Pediatr. 2016 Aug 7;53 Suppl 1:S50-S56
pubmed: 27771640
Expert Rev Vaccines. 2015 Jan;14(1):99-117
pubmed: 25373435
J Public Health Policy. 2017 Feb;38(1):16-36
pubmed: 28077864

Auteurs

Mohamed F Jalloh (MF)

Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, USA.

Elisabeth Wilhelm (E)

Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, USA.

Neetu Abad (N)

Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, USA.

Dimitri Prybylski (D)

Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH